These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29104001)

  • 21. An Impressive Case of "Honeycomb" In-Stent Restenosis.
    Lorenzoni G; Merella P; Viola G; Marziliano N; Casu G
    J Invasive Cardiol; 2018 Sep; 30(9):E99. PubMed ID: 30158330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial and late efficacy of everolimus-eluting stents for small and non-small coronary lesions from evaluating delayed late loss study.
    Tama N; Uzui H; Horita Y; Namura M; Tada H
    Heart Vessels; 2017 Dec; 32(12):1415-1423. PubMed ID: 28687988
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Real polymer-free sirolimus- and probucol-eluting versus biodegradable polymer sirolimus-eluting stents for obstructive coronary artery disease: DKPLUS-Wave 1, a multicenter, randomized, prospective trial.
    Chen SL; Ye F; Zhang JJ; Zou JJ; Qian XS; Li F; Yang S; Ge Z; Shan SJ; Li XB; Xu T; Kan J; Lin L; Han YL
    Cardiovasc Ther; 2013 Aug; 31(4):193-200. PubMed ID: 22954234
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of chronic kidney disease on a re-percutaneous coronary intervention for sirolimus-eluting stent restenosis.
    Aoyama Y; Hirayama H; Ishii H; Kobayashi K; Ishikawa K; Takigawa M; Nanasato M; Yoshida Y; Aoyama T; Yoshikawa D; Matsubara T; Murohara T
    Coron Artery Dis; 2012 Dec; 23(8):528-32. PubMed ID: 22975841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of statin therapy intensity on endothelial progenitor cells after percutaneous coronary intervention in diabetic patients. The REMEDY-EPC late study.
    Briguori C; Quintavalle C; D'Alessio F; Donahue M; Roscigno G; De Micco F; Focaccio A; Visconti G; Del Vecchio L; Madonna R; De Caterina R; Condorelli G
    Int J Cardiol; 2017 Oct; 244():112-118. PubMed ID: 28668399
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential impact of cilostazol on restenosis according to implanted stent type (from a pooled analysis of three DECLARE randomized trials).
    Lee SW; Ahn JM; Han S; Park GM; Cho YR; Lee WS; Jang JY; Kwon CH; Lee JY; Kim WJ; Kang SJ; Kim YH; Lee CW; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2013 Nov; 112(9):1328-34. PubMed ID: 23890573
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of statin on restenosis after radius stent implantation in patients with acute coronary syndrome.
    Nishikawa H; Miura S; Shimomura H; Kawamura A; Tsujita K; Shirai K; Matsuo K; Arai H; Saku K
    J Atheroscler Thromb; 2005; 12(6):302-6. PubMed ID: 16394612
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-eluting stent for long coronary artery disease.
    Park SJ; Kim YH
    Indian Heart J; 2008; 60(6):519-23. PubMed ID: 19276489
    [No Abstract]   [Full Text] [Related]  

  • 29. Effects of combined treatment with angiotensin II type 1 receptor blocker and statin on stent restenosis.
    Yoshikawa M; Nakamura K; Nagase S; Sakuragi S; Kusano KF; Matsubara H; Ohe T
    J Cardiovasc Pharmacol; 2009 Feb; 53(2):179-86. PubMed ID: 19188828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
    Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
    JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-stent restenosis is inhibited in a bare metal stent implanted distal to a sirolimus-eluting stent to treat a long de novo coronary lesion with small distal vessel diameter.
    Obata JE; Nakamura T; Kitta Y; Saito Y; Sano K; Fujioka D; Kawabata K; Kugiyama K
    Catheter Cardiovasc Interv; 2013 Nov; 82(6):E777-87. PubMed ID: 23378231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Statins and stent thrombosis.
    Braunersreuther V; Mach F; Montecucco F
    Swiss Med Wkly; 2012; 142():w13525. PubMed ID: 22344522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intimal hyperplasia and vascular remodeling after everolimus-eluting and sirolimus-eluting stent implantation in diabetic patients: the randomized Diabetes and Drug-Eluting Stent (DiabeDES) IV Intravascular Ultrasound trial.
    Antonsen L; Maeng M; Thayssen P; Christiansen EH; Hansen KN; Kaltoft A; Hansen HS; Thuesen L; Lassen JF; Jensen LO
    Catheter Cardiovasc Interv; 2014 May; 83(6):864-72. PubMed ID: 23996918
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Two-year outcomes after first- or second-generation drug-eluting stent implantation in patients with in-stent restenosis. A PRODIGY trial substudy.
    Campo G; Punzetti S; Malagù M; Ferrari R; Valgimigli M
    Int J Cardiol; 2014 May; 173(2):343-5. PubMed ID: 24680246
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential clinical outcomes after 1 year versus 5 years in a randomised comparison of zotarolimus-eluting and sirolimus-eluting coronary stents (the SORT OUT III study): a multicentre, open-label, randomised superiority trial.
    Maeng M; Tilsted HH; Jensen LO; Krusell LR; Kaltoft A; Kelbæk H; Villadsen AB; Ravkilde J; Hansen KN; Christiansen EH; Aarøe J; Jensen JS; Kristensen SD; Bøtker HE; Thuesen L; Madsen M; Thayssen P; Sørensen HT; Lassen JF
    Lancet; 2014 Jun; 383(9934):2047-2056. PubMed ID: 24631162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions).
    Dangas GD; Serruys PW; Kereiakes DJ; Hermiller J; Rizvi A; Newman W; Sudhir K; Smith RS; Cao S; Theodoropoulos K; Cutlip DE; Lansky AJ; Stone GW
    JACC Cardiovasc Interv; 2013 Sep; 6(9):914-22. PubMed ID: 24050859
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-eluting stents for drug-eluting stent restenosis: stick with the old or switch to a new one?
    Kufner S; Kastrati A
    Coron Artery Dis; 2014 Dec; 25(8):633-5. PubMed ID: 25365642
    [No Abstract]   [Full Text] [Related]  

  • 38. Impact of stent diameter and length on in-stent restenosis after DES vs BMS implantation in patients needing large coronary stents-A clinical and health-economic evaluation.
    Zbinden R; von Felten S; Wein B; Tueller D; Kurz DJ; Reho I; Galatius S; Alber H; Conen D; Pfisterer M; Kaiser C; Eberli FR
    Cardiovasc Ther; 2017 Feb; 35(1):19-25. PubMed ID: 27662632
    [TBL] [Abstract][Full Text] [Related]  

  • 39. No easy fixes.
    Taqueti VR
    N Engl J Med; 2013 Oct; 369(15):1392-3. PubMed ID: 24106933
    [No Abstract]   [Full Text] [Related]  

  • 40. Role of statin therapy in the coronary bypass patient.
    Lazar HL
    Ann Thorac Surg; 2004 Aug; 78(2):730-40. PubMed ID: 15276569
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.